These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 13659105)

  • 21. Analeptic action of lysergic acid diethylamide (LSD-25) against pentobarbital.
    APTER JT
    AMA Arch Neurol Psychiatry; 1958 Jun; 79(6):711-5. PubMed ID: 13532082
    [No Abstract]   [Full Text] [Related]  

  • 22. [Dual effect of lysergic acid diethylamide on uterine contractions induced by 5-hydroxytryptamine (serotonin)].
    DELAY J; THUILLIER J
    C R Seances Soc Biol Fil; 1956; 150(7):1335-6. PubMed ID: 13397064
    [No Abstract]   [Full Text] [Related]  

  • 23. On the central action of alkyl derivatives of butyrolactone.
    Prastowski W
    Arch Immunol Ther Exp (Warsz); 1968; 16(5):827-36. PubMed ID: 4387830
    [No Abstract]   [Full Text] [Related]  

  • 24. The CNS action of d-lysergic acid diethylamide (L.S.D.-25).
    SMITH R
    Mod Hosp; 1953 Jan; 80(1):106-10. PubMed ID: 13025280
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mood, behavior and drugs].
    Monti A
    Minerva Med; 1971 May; 62(40 Suppl):33-4. PubMed ID: 5555948
    [No Abstract]   [Full Text] [Related]  

  • 26. A contribution to LSD action on the central cholinergic system.
    Kabes J; Fusek J; Fink Z
    Act Nerv Super (Praha); 1973 May; 15(2):146-7. PubMed ID: 4752663
    [No Abstract]   [Full Text] [Related]  

  • 27. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 28. Lysergic acid diethylamide (LSD-25) antagonists. II. Development of tolerance in man to LSD-25 by prior administration of MLD-41 (1-methyl-d-lysergic acid diethylamide).
    ABRAMSON HA; SKLAROFSKY B; BARON MO; FREMONT-SMITH N
    AMA Arch Neurol Psychiatry; 1958 Feb; 79(2):201-7. PubMed ID: 13497364
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
    Andén NE
    Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of psilocybin on the behavior of normal mice & waltzing mice; comparison with lysergic acid monoethylamide & diethylamide].
    DELAY J; THUILLIER J; NAKAJIMA H; DURANDIN MC
    C R Seances Soc Biol Fil; 1959; 153(2):244-8. PubMed ID: 13663414
    [No Abstract]   [Full Text] [Related]  

  • 31. The action of lysergic acid diethylamide (LSD 25), its 2-brom derivative (BOL 148) and of 5-hydroxytryptamine (5-HT) on the peristaltic reflex of the guinea-pig ileum.
    GINZEL KH
    J Physiol; 1957 Jul; 137(2):62P-3. PubMed ID: 13449894
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of 5-hydroxytryptamine (5HT), D-lysergic acid diethylamide (LSD 25), phenobarbital, nembutal, and two derivatives of phenothiazine on cerebral metabolism in vivo].
    CAHN J; HEROLD M; DUBRASQUET M; BURET JP
    C R Seances Soc Biol Fil; 1957; 151(1):82-5. PubMed ID: 13447322
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of D-Lysergic acid diethylamide and 5-hydroxytryptamine (serotonin) on spinal reflexes in cats.
    WEIDMANN H; CERLETTI A
    Helv Physiol Pharmacol Acta; 1957; 15(3):376-83. PubMed ID: 13480684
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study of the antagonistic psychopathological effects of lysergic acid monoethylamide (LAE-32) & methylphenylisopropylamine (pervitin)].
    CALLIERI B; RAVETTA M
    Rass Neuropsichiatr; 1957; 11(3-4):198-216. PubMed ID: 13506109
    [No Abstract]   [Full Text] [Related]  

  • 35. Behavioral evidence for the stimulation of CNS serotonin receptors by high doses of LSD.
    Trulson ME; Ross CA; Jacobs BL
    Psychopharmacol Commun; 1976; 2(2):149-64. PubMed ID: 136010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentiation of bufotenine-like syndrome induced by diethyltryptamine in reserpinized rats.
    Khazan N; Hirsch A; Sulman FG
    Electroencephalogr Clin Neurophysiol; 1967 Jun; 22(6):589. PubMed ID: 4165027
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of d-lysergic acid diethylamide and 5-hydroxytryptamine on spinal reflex].
    WEIDMANN H
    Helv Physiol Pharmacol Acta; 1957; 15(2):C 43-4. PubMed ID: 13474596
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of mexamine on central effects of lysergic acid diethylamide].
    Mil'shteĭn GI
    Farmakol Toksikol; 1966; 29(6):662-5. PubMed ID: 6000361
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antagonistic action of several lysergic acid derivatives on antidiuresis induced by 5-hydroxytryptamine].
    DE CARO G
    Arch Int Pharmacodyn Ther; 1963 Jan; 141():54-61. PubMed ID: 14025725
    [No Abstract]   [Full Text] [Related]  

  • 40. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity].
    Magóné KE; Borsy J; Balogh T
    Acta Pharm Hung; 1973 Sep; 43(5):200-6. PubMed ID: 4755753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.